Cardiol Therapeutics Inc. (TSE:CRDL – Get Free Report) shares traded down 2% during mid-day trading on Tuesday . The stock traded as low as C$2.36 and last traded at C$2.41. 48,885 shares changed hands during trading, a decline of 65% from the average session volume of 141,018 shares. The stock had previously closed at C$2.46.
Cardiol Therapeutics Stock Down 3.3 %
The firm has a market capitalization of C$152.36 million, a PE ratio of -5.47 and a beta of 0.75. The company has a fifty day moving average price of C$2.20 and a 200-day moving average price of C$1.58. The company has a debt-to-equity ratio of 0.52, a quick ratio of 6.84 and a current ratio of 5.29.
About Cardiol Therapeutics
Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx for patients hospitalized with COVID-19, as well as for the treatment of recurrent pericarditis and acute myocarditis.
See Also
- Five stocks we like better than Cardiol Therapeutics
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Comprehensive PepsiCo Stock Analysis
- What Are the U.K. Market Holidays? How to Invest and Trade
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Insider Trading – What You Need to Know
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.